Authors


Sarah Melvin

Latest:

Inappropriate Antimicrobial Use in the Emergency Department for Skin and Soft Tissue Infections

Studies have shown high rates of inappropriate antibiotic prescribing and opportunity for improvement when it comes to ABSSSIs.


José Mauro Peralta, PhD

Latest:

A True Case Definition of Zika Virus Infection Should Still Be Pursued in Arbovirus Co-Transmission Areas

Differences in the clinical presentations of ZIKV infection which are occurring in different parts of the world might be an obstacle to setting a case definition that is good for use in all areas.


JENNIFER BAILEY, PHARMD

Latest:

New Initiatives for HIV Taking Off This Year

Advances in antiretroviral therapies increase opportunities for patients with HIV to have more successful treatment outcomes.


RAZIEH KEBRIAEI, PHD+

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


MICHAEL J. RYBAK, PHARMD, MPH, PHD+*

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


Liza Vaezi, PharmD, MSc, BCPS-AQID

Latest:

Early Adjunctive Corticosteroids Do Not Improve Outcomes in HIV-Negative Adults With PcP

The clinical characteristics and outcomes of Pneumocystis jirovecii pneumonia differ in immunocompromised patients with and without HIV.


Lisa Astor

Latest:

Herpes Zoster Vaccine Subunit Prevents Herpes Zoster Episodes Following HSCT

The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.


Pat Smith

Latest:

Is the Medical Community Behind the Times When It Comes to Treating Lyme?

Lyme Disease Association President, Pat Smith, takes on the major problems surrounding Lyme disease today.




CHRISTOPHER MCCOY, PHARMD, BCPS AQ-ID

Latest:

The Ultimate Infectious Disease Pharmacist Holiday Wish List

In case you were wondering what to get the infectious disease (ID) pharmacist in your life for the upcoming holidays.


Fatia Kasumu

Latest:

Australian Breakfast Buffet Links Salmonella Outbreak to Eggs

Cross-contamination of eggs is believed to have been the cause of a Salmonella outbreak from an Australian hotel.


Nicola M. Parry, BVSc, MRCVS, MSc, DipACVP ELS

Latest:

Piperacillin-Tazobactam Very Disruptive to Gut Flora

Additionally, its use is associated with colonization of the gastrointestinal tract by lower relative quantities of some potentially protective bacterial organisms.


Jared Kaltwasser

Latest:

Hospitals Finds Low Rates of Asymptomatic Toxigenic C difficile Carriage

The study was designed to help scientists better understand how to prevent in-hospital transmission of C difficile.



John W. Ahern, PharmD*

Latest:

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.


Rachel V. Marini, PharmD*

Latest:

The Continued Search for Optimal Daptomycin Dosing Strategies in VRE Bloodstream Infections

Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.


John Parkinson

Latest:

FDA Approves Antibiotic for Uncomplicated UTIs

Pivmecillinam (Pivya) was given the nod from the federal agency, and is indicated for female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.


Megan Seddon, PharmD

Latest:

Staying Ahead of the Curve: Implementing AUC-Guided Vancomycin Dosing

Evidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.


Jill Murphy

Latest:

NFID Urges Americans to Receive Influenza and Pneumococcal Vaccines

The NFID released data revealing that only 52% of adults in the United States plan to get vaccinated against the flu this season.


Andrew Berti, PharmD

Latest:

Synergy Between Antibiotics and The Innate Immune System

Growing evidence suggests that antimicrobials also interact with host innate immunity to provide potent indirect effects which enhance bacterial clearance and may result in more rapid and complete effects


Jeffrey M. Rybak, PharmD, PhD*

Latest:

Candida auris Is Changing the Paradigm of Antifungal-Resistant Candida

Candida auris is an emerging health care–associated multidrug-resistant fungal pathogen with public health concerns more similar to those of extensively drug-resistant bacterial pathogens than other species of Candida.


Sarah L. Spitznogle, PharmD*

Latest:

Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens

Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex.


David R. Ha, PharmD, BCIDP

Latest:

Expanding the Antibiotic Stewardship Team Can Lead to Greater Adoption of Practices

There is value in leveraging the contributions of nurses, laboratorians, and informaticists in antimicrobial stewardship.



Jeanne-Claire Fink

Latest:

An NYC Nurse Journals Through the Worst Week of COVID-19

A New York City nurse reflects on "peak-week" in a COVID unit.


Patrick Campbell

Latest:

Email Reminders for Influenza Vaccine Uptake May Be Less Effective in Patients with Diabetes

Analysis of the NUDGE-FLU study reveals electronic nudges designed to boost influenza vaccination were more effective in older adults without diabetes, highlighting the need for tailored approaches in diabetes populations.


Drew Halbur, BSPharm, BCACP, AAHIVP

Latest:

A Pharmacist's Role in HIV Antiretroviral Stewardship in the Hospital

Pharmacists play vital roles in optimizing HIV treatment outcomes in multiple ways and in all medical settings.


Kirk Hevener, PharmD, PhD

Latest:

Study Shows Sulfonamide Antibacterials Capable of Reversing Azole Resistance in Candida albicans

Preliminary studies provide convincing evidence for the synergistic use of sulfonamide agents with azole antifungals.


Rachel Lutz

Latest:

CDC Recommends Update to Hepatitis C Virus Screening

The CDC made this recommendation after reviewing relevant literature, and noting that complete testing jumped from about only two-thirds of patients to nearly all patients.

© 2024 MJH Life Sciences

All rights reserved.